LM1701
17:1 Lyso PA
Manufacturer: Sigma Aldrich
CAS Number: 1246298-35-0
Synonym(S): 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphate (ammonium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 EA | LM1701-1-EA | In Stock | ₹ 17,872.08 |
LM1701 - 1 EA
In Stock
Quantity
1
Base Price: ₹ 17,872.08
GST (18%): ₹ 3,216.974
Total Price: ₹ 21,089.054
form
methanol solution
packaging
pkg of 1 × 1 mL (LM1701-1EA)
manufacturer/tradename
Avanti Polar Lipids
concentration
~10 μg/mL (Refer to C of A for lot specific concentration. )
application(s)
lipidomicsmetabolomics
shipped in
dry ice
storage temp.
−20°C
SMILES string
O[C@](COP([O-])(O)=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O.[NH4+]
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 1246298-35-0 | 17:1 Lyso PA ammonium salt | A2B Chem | -- |
Related Products
Description
- General description: Lysophosphatidic acid (Lyso PA) is a water-soluble lipid,[1] localized to all cells and tissues in mammals.[2]
- Application: 17:1 Lyso PA or 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphate (ammonium salt) has been used as an internal standard for unsaturated lysophosphatidic acid (LPA) ester and cyclic LPA ethers in reversed-phase ultra-performance liquid chromatography-tandem mass spectrometry (UPLC/MS/MS).[3]
- Biochem/physiol Actions: Lysophosphatidic acid (Lyso PA) is considered as a biological modulator of various functions in the cell.[4] It is a potent signaling molecule[2] with growth-factor-like actions.[1] Lyso PA regulates cell proliferation, survival, cytoskeletal modification and calcium influx.[2] It is associated with smooth-muscle contraction and platelet aggregation. It is also known to regulate blood pressure. Lyso PA possess extensive biological actions and is involved in the progression of several human cancer.[1]
- Packaging: 2 mL Amber Glass Sealed Ampule (LM1701-1EA)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
Target Organs
Eyes
WGK
WGK 2
Compare Similar Items
Show Difference
form: methanol solution
packaging: pkg of 1 × 1 mL (LM1701-1EA)
manufacturer/tradename: Avanti Polar Lipids
concentration: ~10 μg/mL (Refer to C of A for lot specific concentration. )
application(s): lipidomicsmetabolomics
shipped in: dry ice
storage temp.: −20°C
SMILES string: O[C@](COP([O-])(O)=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O.[NH4+]
form:
methanol solution
packaging:
pkg of 1 × 1 mL (LM1701-1EA)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
~10 μg/mL (Refer to C of A for lot specific concentration. )
application(s):
lipidomicsmetabolomics
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
O[C@](COP([O-])(O)=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O.[NH4+]
form: powder
packaging: 1 ea of 1 × (with stopper and crimp cap (LM1900-1EA))
manufacturer/tradename: Avanti Polar Lipids
concentration: __
application(s): lipidomicsmetabolomics
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OP([O-])(O)=O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+]
form:
powder
packaging:
1 ea of 1 × (with stopper and crimp cap (LM1900-1EA))
manufacturer/tradename:
Avanti Polar Lipids
concentration:
__
application(s):
lipidomicsmetabolomics
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OP([O-])(O)=O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+]
form: powder
packaging: 1 ea of 1 × (with stopper and crimp cap (LM1904-1EA))
manufacturer/tradename: Avanti Polar Lipids LM1904
concentration: __
application(s): lipidomicsmetabolomics
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
form:
powder
packaging:
1 ea of 1 × (with stopper and crimp cap (LM1904-1EA))
manufacturer/tradename:
Avanti Polar Lipids LM1904
concentration:
__
application(s):
lipidomicsmetabolomics
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
form: powder
packaging: 1 ea of 1 × (with stopper and crimp cap (LM1905-1EA))
manufacturer/tradename: Avanti Polar Lipids LM1905
concentration: __
application(s): __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](O)[C@@H](OP([O-])(O)=O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
form:
powder
packaging:
1 ea of 1 × (with stopper and crimp cap (LM1905-1EA))
manufacturer/tradename:
Avanti Polar Lipids LM1905
concentration:
__
application(s):
__
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](O)[C@@H](OP([O-])(O)=O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+].[NH4+]